Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7923186rdf:typepubmed:Citationlld:pubmed
pubmed-article:7923186lifeskim:mentionsumls-concept:C0006142lld:lifeskim
pubmed-article:7923186lifeskim:mentionsumls-concept:C0014257lld:lifeskim
pubmed-article:7923186lifeskim:mentionsumls-concept:C0596890lld:lifeskim
pubmed-article:7923186lifeskim:mentionsumls-concept:C0007587lld:lifeskim
pubmed-article:7923186lifeskim:mentionsumls-concept:C0039286lld:lifeskim
pubmed-article:7923186lifeskim:mentionsumls-concept:C0021102lld:lifeskim
pubmed-article:7923186lifeskim:mentionsumls-concept:C0018270lld:lifeskim
pubmed-article:7923186lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:7923186lifeskim:mentionsumls-concept:C2349975lld:lifeskim
pubmed-article:7923186pubmed:issue21lld:pubmed
pubmed-article:7923186pubmed:dateCreated1994-11-23lld:pubmed
pubmed-article:7923186pubmed:abstractTextMagnetic resonance imaging at high spatial resolution and histochemical staining were applied to monitor the influence of tamoxifen versus estrogen on the growth, endothelial density, and extent of necrosis in tumors of MCF7 human breast cancer cells implanted in nude mice. Concomitantly with tamoxifen growth arrest, a highly significant decrease, by more than 2-fold, in the endothelial density of viable tumor regions had occurred, together with a significant increase in the extent of necrosis. The results suggest that the antiestrogenic activity of tamoxifen in breast cancer, which results in enhanced necrosis and tumor regression, is due to the inhibition of angiogenesis and of endothelial growth, thus reducing vascularization and impairing tumor perfusion.lld:pubmed
pubmed-article:7923186pubmed:languageenglld:pubmed
pubmed-article:7923186pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7923186pubmed:citationSubsetIMlld:pubmed
pubmed-article:7923186pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7923186pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7923186pubmed:statusMEDLINElld:pubmed
pubmed-article:7923186pubmed:monthNovlld:pubmed
pubmed-article:7923186pubmed:issn0008-5472lld:pubmed
pubmed-article:7923186pubmed:authorpubmed-author:GoldbergIIlld:pubmed
pubmed-article:7923186pubmed:authorpubmed-author:DeganiHHlld:pubmed
pubmed-article:7923186pubmed:authorpubmed-author:HorowitzAAlld:pubmed
pubmed-article:7923186pubmed:authorpubmed-author:HaranE FEFlld:pubmed
pubmed-article:7923186pubmed:authorpubmed-author:MaretzekA FAFlld:pubmed
pubmed-article:7923186pubmed:issnTypePrintlld:pubmed
pubmed-article:7923186pubmed:day1lld:pubmed
pubmed-article:7923186pubmed:volume54lld:pubmed
pubmed-article:7923186pubmed:ownerNLMlld:pubmed
pubmed-article:7923186pubmed:authorsCompleteYlld:pubmed
pubmed-article:7923186pubmed:pagination5511-4lld:pubmed
pubmed-article:7923186pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7923186pubmed:meshHeadingpubmed-meshheading:7923186-...lld:pubmed
pubmed-article:7923186pubmed:meshHeadingpubmed-meshheading:7923186-...lld:pubmed
pubmed-article:7923186pubmed:meshHeadingpubmed-meshheading:7923186-...lld:pubmed
pubmed-article:7923186pubmed:meshHeadingpubmed-meshheading:7923186-...lld:pubmed
pubmed-article:7923186pubmed:meshHeadingpubmed-meshheading:7923186-...lld:pubmed
pubmed-article:7923186pubmed:meshHeadingpubmed-meshheading:7923186-...lld:pubmed
pubmed-article:7923186pubmed:meshHeadingpubmed-meshheading:7923186-...lld:pubmed
pubmed-article:7923186pubmed:meshHeadingpubmed-meshheading:7923186-...lld:pubmed
pubmed-article:7923186pubmed:meshHeadingpubmed-meshheading:7923186-...lld:pubmed
pubmed-article:7923186pubmed:meshHeadingpubmed-meshheading:7923186-...lld:pubmed
pubmed-article:7923186pubmed:meshHeadingpubmed-meshheading:7923186-...lld:pubmed
pubmed-article:7923186pubmed:meshHeadingpubmed-meshheading:7923186-...lld:pubmed
pubmed-article:7923186pubmed:meshHeadingpubmed-meshheading:7923186-...lld:pubmed
pubmed-article:7923186pubmed:meshHeadingpubmed-meshheading:7923186-...lld:pubmed
pubmed-article:7923186pubmed:meshHeadingpubmed-meshheading:7923186-...lld:pubmed
pubmed-article:7923186pubmed:year1994lld:pubmed
pubmed-article:7923186pubmed:articleTitleTamoxifen enhances cell death in implanted MCF7 breast cancer by inhibiting endothelium growth.lld:pubmed
pubmed-article:7923186pubmed:affiliationChemical Physics Department, Weizmann Institute of Science, Rehovot, Israel.lld:pubmed
pubmed-article:7923186pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7923186pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:7923186pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7923186lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7923186lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7923186lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7923186lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7923186lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7923186lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7923186lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7923186lld:pubmed